← Apex Wire
Insider activity — ATTOAttovia Therapeutics, Inc.

14 Form 4 filings for ATTO between 2026-08-06 and 2026-08-13, from 13 filers. 14 discretionary (0 sales, 0 purchases). None state a filing-level total — that aggregate began on 2026-08-17 — so each row below shows only its largest transaction.

Filings 14 Filers 13 Discretionary 14 Routine 0

Filings
FiledFilerRoleAction Shares
largest txn
Price Filing totalTxns
2026-08-13 WALSH COLIN 1,957,134 27
2026-08-13 WSLS EMP ONSHORE INVESTMENTS, L.P. 1,957,134 27
2026-08-10 Deep Track Biotechnology Master Fund, Ltd. 1,957,138
2026-08-10 venBio Global Strategic Fund IV, L.P. 2,311,870 4
2026-08-07 Redmile Biopharma Investments III, L.P. 782,854 3
2026-08-07 Sanofi 782,855 2
2026-08-06 FHMLS XI, L.L.C. 1,749,192 5
2026-08-06You Angie (Director at Attovia Therapeutics, Inc.) filed a Form 4; no parseable transaction details were found in the filing.
2026-08-06GOLD MITCHELL (Director at Attovia Therapeutics, Inc.) filed a Form 4; no parseable transaction details were found in the filing.
2026-08-06Odrowaz Zaneta (Chief Business Officer at Attovia Therapeutics, Inc.) filed a Form 4; no parseable transaction details were found in the filing.
2026-08-06Veiby Petter (Chief Scientific Officer at Attovia Therapeutics, Inc.) filed a Form 4; no parseable transaction details were found in the filing.
2026-08-06Chen Hubert (Chief Medical Officer at Attovia Therapeutics, Inc.) filed a Form 4; no parseable transaction details were found in the filing.
2026-08-06Attovia Therapeutics, Inc. (Chief Financial Officer at Attovia Therapeutics, Inc.) filed a Form 4; no parseable transaction details were found in the filing.
2026-08-06Attovia Therapeutics, Inc. (President and CEO at Attovia Therapeutics, Inc.) filed a Form 4; no parseable transaction details were found in the filing.
14 filings · 13 filers · disclosed totals only $0 (0/14)
Elsewhere